Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: Modulation by apolipoprotein E and apolipoprotein C

Journal of Lipid Research

Volumn 37, Issue 4, 1996, Pages 754-763

  Van Barlingen, Harrold H J J ^a   De Jong, Harmen ^a   Erkelens, D Willem ^a   De Bruin, Tjerk W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

biotin conjugated heparan sulfate; heparan sulfate proteoglycans; low density lipoproteins

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN C; APOLIPOPROTEIN E; CHONDROITIN 4 SULFATE; DERMATAN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; LACTOFERRIN; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIPID COMPOSITION; PRIORITY JOURNAL;

APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; BINDING, COMPETITIVE; GLYCOSAMINOGLYCANS; HEPARITIN SULFATE; HUMANS; LIPOPROTEIN LIPASE; LIPOPROTEINS; PROTEIN BINDING; TRIGLYCERIDES;

EID: 0029985679     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Eckel, R. H. 1989. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic disease. N. Engl. J. Med. 320: 1060-1068.
2. Holdsworth, G., J. Stocks, P. Dodson, and D. J. Galton. 1982. An abnormal triglyceride-rich lipoprotein containing excess sialylated apoprotein C-III. J. Clin. Invest. 69: 932-939.
3. Olivecrona, T., and G. Bengtsson-Olivecrona. 1993. Lipoprotein lipase and hepatic lipase. Curr. Opin. Lipidol. 4: 187-196.
4. Brown, M. S., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low-density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2: 65-72.
5. Krempler, F., G. M. Kostner, W. Friedl, B. Paulweber, H. Bauer, and F. Sandhofer. 1987. Lipoprotein binding to cultured human hepatoma cells. J. Clin. Invest. 80: 401-408.
6. Nagata, Y., J. Chen, and A. D. Cooper. 1988. Role of low density lipoprotein receptor-dependent and -independent sites in binding and uptake of chylomicron remnants in rat liver. J. Biol Chem. 263: 15151-15158.
7. Weisgraber, K. H. 1994. Apolipoprotein E: structure-function relationships. Adv. Prot. Chem. 45: 249-302.
8. Sherrill, B. C., T. L. Innerarity, and R. W. Mahley. 1980. Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. J. Biol. Chem. 255: 1804-1807.
9. Shimano, H., Y. Namba, J. Ohsuga, M. Kawamura, K. Yamamoto, M. Shimada, T. Gotoda, K. Harada, Y. Yazaki, and N. Yamada. 1994. Secretion-recapture process of apolipoprotein E in hepatic uptake of chylomicron remnants in transgenic mice. J. Clin. Invest. 93: 2215-2223.
10. Ji, Z-S., S. Fazio, and R. W. Mahley. 1994.Variable heparan sulfate proteoglycan binding of apolipoprotein E variants may modulate the expression of type III hyperlipoproteinemia. J. Biol. Chem. 269: 13421-13428.
11. Ji, Z-S., W. J. Brecht, R. D. Miranda, M. M. Hussain, T. L. Innerarity, and R. W. Mahley. 1993. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells. J. Biol. Chem. 268: 10160-10167.
12. Ji, Z-S., S. Fazio, Y-L. Lee, and R. W. Mahley. 1994. Secretion-capture role for apolipoprotein E in remnant lipoprotein metabolism involving cell surface heparan sulfate proteoglycans. J. Biol. Chem. 269: 2764-2772.
13. Windler, E., and R. J. Havel. 1985. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J. Lipid Res. 26: 556-565.
14. Kowal, R. C., J. Herz, K. H. Weisgraber, R. W. Mahley, M. S. Brown, and J. L. Goldstein. 1992. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor-related protein. J. Biol. Chem. 265: 10771-10779.
15. Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb. Vasc. Biol. 15: 963-971.
16. Weisgraber, K. H., R. W. Mahley, R. C. Kowal, J. Herz, J. L. Goldstein, and M. S. Brown. 1992. Apolipoprotein C-I modulates the interaction of apolipoprotein E with β-migrating very low density lipoproteins (β-VLDL) and inhibits binding of β-VLDL to low density lipoprotein-related protein. J. Biol. Chem. 265: 22453-22459.
17. De Silva, H. V., S. J. Lauer, R. W. Mahley, K. H. Weisgraber, and J. M. Taylor. 1993. Apolipoproteins E and C-III have opposing roles in the clearance of lipoprotein remnants in transgenic mice. Biochem. Soc. Trans. 21: 483-487.
18. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Ginsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
19. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93: 1683-1690.
20. De Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonet, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E. J. Biol. Chem. 269: 2324-2335.
21. Ji, Z-S., D. A. Sanan, and R. W. Mahley. 1995. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans. J. Lipid Res. 36: 583-592.
22. Hussain, M. M., T. L. Innerarity, W. J. Brecht, and R. W. Mahley. 1995. Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway. J. Biol. Chem. 270: 8578-8587.
23. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomirons to low density lipoprotein-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
24. Mulder, M., P. Lombardi, H. Jansen, T. J. C. van Berkel, R. R. Frants, and L. M. Havekes. 1993. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J. Biol. Chem. 268: 9369-9375.
25. Kawamura, M., H. Shimano, T. Gotoda, K. Harada, M. Shimada, J. Ohsuga, T. Inaba, Y. Watanabe, K. Yamamoto, K. Kozaki, Y. Yazaki, and N. Yamada. 1994. Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells. Arterioscler. Thromb. 14: 235-242.
26. 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. J. Biol. Chem. 268: 14168-14175.
27. van Barlingen, H.H. J. J., L. A. W. Kock, H. A. F. de Man, D. W. Erkelens, and T. W. A. de Bruin. 1996. In vitro lipolysis of human VLDL: effect of different VLDL composition in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia. Atherosclerosis. 121: 75-84.
28. Camejo, G., E. Hurt-Camejo, U. Olsson, and G. Bondjers. 1993. Proteoglycans and lipoproteins in atherosclerosis. Curr. Opin. Lipidol. 4: 385-391.
29. Edwards, I. J., I. J. Goldberg, J. S. Parks, H. Xu, and W. D. Wagner. 1993. Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans. J. Lipid Res. 34: 1155-1163.
30. Zilversmit, D. B. 1995. Atherogenic nature of triglycerides, postprandial lipidemia, and triglyceride-rich remnant lipoproteins. Clin. Chem. 41: 153-158.
31. Ziere, G. J., M. C. M. van Dijk, M. K. Bijsterbosch, and T. J. C. van Berkel. 1992. Lactoferrin uptake by the rat liver. J. Biol. Chem. 267: 11229-11235.
32. Willnow, T. E., J. L. Goldstein, K. Orth, M. S. Brown, and J. Herz. 1992. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267: 26172-26180.
33. Redgrave, T. G., D. C. K. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
34. Castro Cabezas, M., D. W. Erkelens, L. A. W. Kock, and T. W. A. de Bruin. 1994. Postprandial apolipoprotein B100 and B48 metabolism in familial combined hyperlipidemia before and after reduction of fasting plasma triglycerides. Eur. J. Clin. Invest. 24: 669-678.
35. Van Greevenbroek, M. M. J., W. F. Voorhout, D. W. Erkelens, G. van Meer, and T. W. A. de Bruin. 1995. Palmitic acid and linoleic acid metabolism in Caco-2 cells: different triglyceride synthesis and lipoprotein secretion. J. Lipid Res. 36: 13-24.
36. Lyon, M., J. A. Deakin, and J. T. Gallagher. 1994. Liver heparan sulfate structure. J. Biol. Chem. 269: 11208-11215.
37. Baker, J. R., and J. E. Christner. 1993. A competitive assay of lipoprotein:proteoglycan interaction using a 96-well microtitration plate. Anal. Biochem. 184: 388-394.
38. Blumenkrantz, N., and G. Asboe-Hansen. 1977. Quantitative determination of uronic acids with m-hydroxydihenyl. Methods Biochem. Anal. 24: 71-76.
39. Posner, I., C. Wang, and W. J. McConathy. 1983. The comparative kinetics of soluble and heparin-Sepharose-immobilized bovine lipoprotein lipase. Arch. Biochem. Biophys. 226: 306-316.
40. Markwell, M. A. K., S. M. Haas, L. L. Bieber, and N. E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87: 206-210.
41. Norusis, M. J. 1992. Multiple linear regression analysis: procedure regression. In SPSS/PC+, Base System User's Guide. Release 5.0. SPSS Inc. Chicago, Illinois. 303-357.
42. Choi, S. Y., P. Sivaram, D. E. Walker, L. K. Curtiss, D. G. Gretch, S. L. Sturley, A. D. Attie, R. J. Deckelbaum, and I. J. Goldberg. 1995. Lipoprotein lipase association with lipoproteins involves protein-protein interaction with apolipoprotein B. J. Biol. Chem. 270: 8081-8086.
43. Castro Cabezas, M., T. W. A. de Bruin, H. Jansen, L. A. W. Kock, W. Kortlandt, and D. W. Erkelens. 1993. Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler. Thromb. 13: 804-814.
44. Ji, Z-S., and R. W. Mahley. 1994. Lactoferrin binding to heparan sulfate proteoglycans and the LDL receptor-related protein: further evidence supporting the importance of direct binding of remnant lipoproteins to HSPG. Arterioscler. Thromb. 14: 2025-2031.
45. 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase. J. Biol. Chem. 269: 18001-18006.
46. Huettinger, M., H. Retzek, M. Hermann, and H. Goldenberg. 1992. Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. J. Biol. Chem. 267: 18551-18557.
47. Saxena, U., E. Ferguson, and C. L. Bisgaier. 1993. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix. J. Biol. Chem. 268: 14812-14819.
48. Wang, C., J. Hartsuck, and W. J. McConathy. 1992. Structure and functional properties of lipoprotein lipase. Biochim. Biophys. Acta. 1123: 1-17.
49. Mann, W. A., N. Meyer, W. Weber, F. Rinninger, H. Greten, and U. Beisiegel. 1993. Coordinate effect of apolipoprotein E and lipoprotein lipase on binding of lipoproteins to cells. Circulation. 88: I-321 (Abstr.)
50. Saxena, U., M. G. Klein, and I. J. Goldberg. 1990. Metabolism of endothelial cell-bound lipoprotein lipase. J. Biol. Chem. 265: 12880-12886.
51. Rubinstein, A., J. C. Gibson, J. R. Paterniti, G. Kakis, A. Little, H. N. Ginsberg, and W. V. Brown. 1985. Effect of heparin-induced lipolysis on the distribution of apolipoprotein E among lipoprotein subclasses. J. Clin. Invest. 75: 710-721.